Breaking News – April 18, 2012
Lilly wins FDA approval for Alzheimer’s imaging agent
New Lilly drug has small sales potential
Is the FDA killing innovation?
Draft Guidance for Industry on Standards for Clinical Trial Imaging Endpoints; Availability
FDA approves medical-image software for Apple mobile devices
FDA approves first mobile diagnostic viewing app
FDA approves F-18 NaF for PET bone scans
AVEO Pharmaceuticals starts exploratory biomarker trial enrollment
